CCL2 and cancer: Furthermore, results that plasma concentrations of pro-inflammatory cytokines and angiogenic factors were elevated in MCP-1−/− mice indicates the existence of compensatory mechanisms that up regulates the production of these cancer promoting factors, which support LLC progression in the absence of MCP-1.